If you thought Metformin’s only job was keeping A1c in check, think again. This humble first-line diabetes workhorse may also be quietly pulling its weight in the postoperative pain game — at least after lumbar fusion.
A new retrospective cohort study asks a question spine surgeons didn’t know they needed answered: Does metformin use influence postoperative opioid consumption and patient-reported outcomes after lumbar fusion?
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
